Medical Advisory Board

At CR&T, our activities and funding objectives are guided by the expertise of a world-class Medical Advisory Board, featuring some of the world’s foremost physician-scientists in cancer treatment research.

Advisory board members are widely recognized for their contributions to the advancement of research in various types of blood cancers, including myeloproliferative neoplasms (MPNs), leukemia, non-Hodgkin’s lymphoma, Hodgkin’s disease and multiple myeloma, as well as other common cancers such as breast and lung cancer.

Current CR&T Medical Advisory Board members include: